Botox in the Healing of Surgical Wounds of the Neck

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

May 5, 2016

Study Completion Date

May 5, 2016

Conditions
Scar
Interventions
DRUG

Botulinum Toxin Type A

"A vial of Botulinum Toxin A containing 100U of Botox will be reconstituted with 2mL of normal saline for a concentration of 50U/mL.~5 units (0.1mL) of Botulinum Toxin a will be injected at midline and 1.5cm lateral to midline, bidirectionally, following a thyroidectomy or parathyroidectomy."

DRUG

Normal Saline

0.1mL of normal saline in a placebo vial containing 2mL of normal saline will be injected along three sites (midline and 1.5cm lateral from midline) following a thyroidectomy or parathyroidectomy.

Trial Locations (1)

B3H 1V7

Queen Elizabeth II Hospital, Halifax

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Nova Scotia Health Authority

OTHER